Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

SparingVision and Intellia Therapeutics establish strategic collaboration for ocular diseases

Oct. 14, 2021

VRDN-002 demonstrates promising PK profile in nonhuman primates

Oct. 7, 2021

Researchers develop a murine model of retinal disease

Oct. 7, 2021

VRDN-001 potently inhibits IGF-1R signaling in vitro

Oct. 6, 2021

Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis

Sep. 23, 2021

Achillion Pharmaceuticals identifies new complement factor D inhibitors

Sep. 17, 2021

CNGA1 behind retinal degeneration, murine model shows

Sep. 17, 2021

Boehringer Ingelheim describes new plasma kallikrein inhibitors

Sep. 7, 2021

KalVista presents structure and preclinical data for pKA inhibitor KVD-001

Aug. 25, 2021

Regeneron reports topline phase II results on 8-mg dose of aflibercept in wet AMD

Aug. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...